17 JAN 2022

Powell Testimony, Endemic, Q4 Earnings

News and insights

Key Points

Powell testimony and Fed official vow to bring down inflation and leave the door open to even more aggressive tapering than the base line suggested in the dot plots; IG benchmarks & ETFs suffer from their interest rate duration

Certain govts start to attempt the ‘endemic’ discussion while the WHO warned against this narrative; certain re-open pockets remain attractive given the govt willingness to loosen up the restrictions; COVID resurgence in China posts a concern to the global supply chain and the manufacturing sector

Q4 earnings started by US banks disappointing on trading revenues and rising costs; earnings quality and visibility will be key going into a regime with rising dispersion and a tightening cycle, another reason in favour of active credit- and rates management

High beta credit spreads took cue from equity vol but at a much lower magnitude; curve steepening and quality compression remain the trend as investors prefer ‘default’ risk over duration risk

Back to all

Connect with us

Area(s) of interest
This field is for validation purposes and should be left unchanged.

Utoquai 55
8008 Zürich
Switzerland

Investment Solutions
+41 43 888 45 60

Advisory
+41 43 888 60 60